News & Analysis as of

Controlled Substances Mental Health

Womble Bond Dickinson

FDA Rejects MDMA Treatment for PTSD; Setbacks and New Directions

Womble Bond Dickinson on

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) granted breakthrough therapy designation to MDMA (a.k.a., ecstasy) in 2017 as part of...more

McDermott+

Exploring the Virtual Care Policy Landscape One Year Post-PHE

McDermott+ on

May 11, 2024, marked one year since the end of the COVID-19 public health emergency (PHE), and not much has changed in Medicare telehealth policy. We are still operating under temporary waivers and flexibilities and, as a...more

Fisher Phillips

How Will Psychedelics Impact the Workplace as Therapeutic Treatment Gains Popularity? 4 Things Employers Should Know

Fisher Phillips on

You may think of “magic mushrooms” as nothing but a novelty, but psychedelics like psilocybin are gaining popularity as a therapeutic mental health treatment – raising questions about their impact on the workplace. Are your...more

Womble Bond Dickinson

An Update on Medical Research and Legal Battles for Psilocybin

Womble Bond Dickinson on

Scientists continue to research psilocybin as an alternative treatment for multiple neuropsychiatric disorders, including anxiety, depression, and PTSD. We previously highlighted this research in 2021. One area of research is...more

Nelson Hardiman, LLP

Too Much Of A Good Thing?

Nelson Hardiman, LLP on

F. Scott Fitzgerald famously declared that “Too much of anything is bad, but too much champagne is just right.” That may be true, but it now appears that it may have been “Special K” that proved the undoing of beloved actor...more

Benesch

2024 Outlook: Behavioral Health Trends

Benesch on

Healthcare systems are facing significant challenges in recruiting and retaining talent within the burgeoning field of behavioral health services, primarily due to competition from telehealth providers and inconsistent...more

Husch Blackwell LLP

Developing a Regulatory Compliance Checklist for Ketamine-Assisted Therapy

Husch Blackwell LLP on

Ketamine clinics have been on the rise in the U.S. in recent years. As a byproduct of the common practice of prescribing drugs “off-label,” these clinics are not necessarily new in their operating model. Off-label use is the...more

Mintz - Health Care Viewpoints

Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024

On October 10, 2023, the Drug Enforcement Administration (DEA) published another temporary rule extending the COVID-era telemedicine flexibilities that allow physicians and other prescribers to prescribe controlled substances...more

Mandelbaum Barrett PC

Rescheduling Psilocybin: Joshua S. Bauchner Serves as Principal Author of Pro-Bono Amicus Curiae Brief on Behalf of NORML

Mandelbaum Barrett PC on

Firm attorney Joshua S. Bauchner, Chair of the Cannabis and Psychedelics Practice Group, served as the principal author of a pro-bono amicus curiae brief filed on behalf of NORML in support of Petitioners in Dr. Sunil...more

Sheppard Mullin Richter & Hampton LLP

Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule

This month, the Drug Enforcement Administration (“DEA”), in conjunction with the Substance Abuse and Mental Health Services Administration (“SAMHSA”), issued a Second Temporary Rule further extending the telemedicine waivers...more

Manatt, Phelps & Phillips, LLP

[Webinar] Navigating the Mainstreaming of Psychedelic Drugs in the United States - October 3rd, 1:00 pm - 2:00 pm ET

In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold. In the United States, many types of psychedelics are being investigated for use in treating an array of mental health...more

Dickinson Wright

DEA Reverses Course and Extends Telehealth Prescriptions of Controlled Substances

Dickinson Wright on

Reversing previously proposed rules, the DEA recently issued new guidance allowing the continued use of telehealth when prescribing controlled substances following the end of the Covid-19 public health emergency (“PHE”)....more

Womble Bond Dickinson

Move Over Cannabis, the Movement to Legalize Psychedelic Mushrooms Is Ready to Share the Spotlight

Womble Bond Dickinson on

For more than 20 years, the movement to decriminalize and/or legalize cannabis has gained momentum and support across the U.S., resulting in substantial legal reform at the state level that continues today. In recent years, a...more

Rivkin Radler LLP

Fraud Week: CT Behavioral Health Providers Sentenced

Rivkin Radler LLP on

We’ll wrap up this edition of Fraud Week with a look at two Connecticut behavioral health providers, one bad and one very, very bad. First, Alicia Thompkins, a social worker from Hartford, pleaded guilty on April 27 to...more

The Rodman Law Group, LLC

Proposition 122 Passes in Colorado

Prop 122 successfully passed in November, but several questions still remain on Colorado’s creation of a legal regulatory framework to support psychedelic substances. This past November, Colorado voters approved the...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Colorado Voters Pass Proposition to Allow Regulated Use of Psychedelic Mushrooms

On November 8, 2022, voters in Colorado passed a ballot initiative to decriminalize possession of and legalize limited use of psychedelic mushrooms and other plant- and fungi-derived psychedelic drugs by those 21 years of age...more

The Rodman Law Group, LLC

Colorado Voters Eye Decriminalization of Psilocybin

This November, Colorado could see some big changes in the area of psychedelics as activists believe they have enough signatures to place a measure on the state’s ballot that would legalize possession of psilocybin and create...more

Manatt, Phelps & Phillips, LLP

State Toolkit to End the Nation’s Drug Overdose Epidemic: Leading-Edge Actions and Strategies to Remove Barriers to Evidence-based...

With drug overdose deaths reaching record numbers, policymakers and other stakeholders must increase their efforts to end the nation’s drug overdose epidemic with targeted, evidence-based interventions and emerging best...more

McGuireWoods LLP

Edible Bites Episode 7: Oregon Psilocybin Services Act, Measure 109 Overview and Licensure

McGuireWoods LLP on

In episode seven of the Edible Bites video webinar series, McGuireWoods’ Kate Hardey and Royce DuBiner examine all the facets of the Oregon Psilocybin Services Act, Measure 109. Tune in to their discussion of this Oregon law,...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Tripping on Hallucinogenics in Oregon: Two New Measures Decriminalize Certain Narcotics and Legalize Psilocybin Therapy

Oregon voters approved two groundbreaking measures in the 2020 election season to become the first state in the nation to decriminalize personal possession of small amounts of certain controlled substances (Measure 110) and...more

Womble Bond Dickinson

States are Easing Laws and Legalizing Recreational Drugs—Not Just Marijuana

Womble Bond Dickinson on

While there may still be uncertainty as to the full results of the 2020 election, one thing has been decided: Americans want to ease the laws criminalizing recreational drugs. On Tuesday, residents of Arizona, Montana, New...more

Cozen O'Connor

Are Psychedelic Mushrooms the New Cannabis?

Cozen O'Connor on

On Tuesday November 3, 2020, Oregon became the first state to legalize psychedelic mushrooms. Approximately 56 percent of Oregon voters cast their ballots in favor of Measure 109, which legalized psilocybin, commonly referred...more

The Rodman Law Group, LLC

Oregon Takes the Lead on Drug Policy Reform

In the 2020 election, Oregon voters demonstrated an overwhelming appetite for drug policy reform. Election results show landslide victories for two groundbreaking measures – one decriminalizing all drugs, and one legalizing...more

Womble Bond Dickinson

Oral Film Medication Delivery of Psychedelics: A Game Changer to Treat Depression?

Womble Bond Dickinson on

Over 300 million people live with depression worldwide. WHO estimates that almost 800,000 people die annually from suicide. Although antidepressants and counseling can be effective treatments for many individuals, there is...more

Baker Donelson

Texas Medical Board Proposes New Rules on Heels of Relaxed Telemedicine Laws

Baker Donelson on

The Texas Medical Board recently proposed changes to its telemedicine regulations (22 Tex. Admin. Code §§ 174.1 – 174.12) to follow the amendments to Section 111 of the Texas Occupations Code governing the practice of...more

29 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide